|
|
Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.
In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.
The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.
By definition, when a medication is administered intravenously, its bioavailability is 100%.
Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.